T细胞受体-话题@MedSci

#T细胞受体#

12篇内容 | 1138人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2215705, encodeId=67812215e05cb, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a> <a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a> <a href='/topic/show?id=7f1112414da' target=_blank style='color:#2F92EE;'>#MYD88#</a>, objectTitle=Science子刊：通过将CAR和TCR的优势相结合，Co-STAR T 细胞有望高效地治疗癌症, objectType=article, longId=835230, objectId=ff3f83523040, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240719/1721345193550_2185383.png, objectUrl=/article/show_article.do?id=ff3f83523040, replyNumber=0, likeNumber=67, createdTime=2024-07-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214578, encodeId=277722145e84d, content=<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a> <a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a> <a href='/topic/show?id=fbfd11583882' target=_blank style='color:#2F92EE;'>#TCR-T细胞#</a>, objectTitle=Nat Med：临床试验表明TCR-T细胞免疫疗法有望治疗转移性结直肠癌, objectType=article, longId=834168, objectId=f72e83416868, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240712/1720739875458_2185383.png, objectUrl=/article/show_article.do?id=f72e83416868, replyNumber=0, likeNumber=55, createdTime=2024-07-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1548141, encodeId=c4d315481417d, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=【Cell】T细胞受体结构图像，揭秘T细胞受体作用机制！, objectType=article, longId=736676, objectId=d66de36676d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d66de36676d4, replyNumber=0, likeNumber=98, createdTime=2022-08-24, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d66de36676d4, moduleTitle=【Cell】T细胞受体结构图像，揭秘T细胞受体作用机制！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d66de36676d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548140, encodeId=33be15481404d, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Science：通过抓键工程化提高T细胞受体的效力，同时减少脱靶毒性, objectType=article, longId=724216, objectId=8a2ee2421629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2ee2421629, replyNumber=0, likeNumber=80, createdTime=2022-04-15, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2ee2421629, moduleTitle=Science：通过抓键工程化提高T细胞受体的效力，同时减少脱靶毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2ee2421629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548139, encodeId=71e51548139ae, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Allergy：T细胞受体测序表明银屑病是是一种以皮肤为重点的过敏原驱动的疾病, objectType=article, longId=301188, objectId=735430118818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=735430118818, replyNumber=0, likeNumber=88, createdTime=2022-03-21, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=735430118818, moduleTitle=Allergy：T细胞受体测序表明银屑病是是一种以皮肤为重点的过敏原驱动的疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=735430118818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548138, encodeId=42c9154813859, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后, objectType=article, longId=213759, objectId=0010213e5918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0010213e5918, replyNumber=0, likeNumber=162, createdTime=2021-07-06, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0010213e5918, moduleTitle=Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0010213e5918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548137, encodeId=bdca154813e3f, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Unum Therapeutics宣布研究性新药（IND）申请：抗体偶联T细胞受体（ACTR）细胞疗法和曲妥珠单抗联合治疗HER2阳性晚期癌症, objectType=article, longId=146626, objectId=e59d146626ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e59d146626ef, replyNumber=0, likeNumber=89, createdTime=2018-08-16, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e59d146626ef, moduleTitle=Unum Therapeutics宣布研究性新药（IND）申请：抗体偶联T细胞受体（ACTR）细胞疗法和曲妥珠单抗联合治疗HER2阳性晚期癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e59d146626ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548136, encodeId=e62e1548136a3, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Gastroenterology：肠道微生物菌群改变导致肝内γδT细胞受体阳性细胞产生白细胞介素17及胆汁淤积性肝病的发病机制的研究, objectType=article, longId=139933, objectId=d8691399338a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8691399338a, replyNumber=0, likeNumber=73, createdTime=2018-06-06, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8691399338a, moduleTitle=Gastroenterology：肠道微生物菌群改变导致肝内γδT细胞受体阳性细胞产生白细胞介素17及胆汁淤积性肝病的发病机制的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8691399338a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548135, encodeId=4d69154813552, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染, objectType=article, longId=107560, objectId=d77410e56005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77410e56005, replyNumber=0, likeNumber=97, createdTime=2017-08-04, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77410e56005, moduleTitle=J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77410e56005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548134, encodeId=5611154813474, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=eLife：T细胞受体基因疗法或可有效改善癌症免疫疗法的安全性, objectType=article, longId=82231, objectId=19b88223132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19b88223132, replyNumber=0, likeNumber=0, createdTime=2016-11-14, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19b88223132, moduleTitle=eLife：T细胞受体基因疗法或可有效改善癌症免疫疗法的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19b88223132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548133, encodeId=88dc15481333c, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Science子刊：挑战常规！同一个T细胞受体诱导两种T细胞亚型产生, objectType=article, longId=76351, objectId=a115e6351d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a115e6351d4, replyNumber=0, likeNumber=85, createdTime=2016-09-02, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a115e6351d4, moduleTitle=Science子刊：挑战常规！同一个T细胞受体诱导两种T细胞亚型产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a115e6351d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548132, encodeId=4866154813255, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Nat Med：T细胞受体疗法(TCR)治疗骨髓瘤疗效良好, objectType=article, longId=67636, objectId=8a3e6e63697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a3e6e63697, replyNumber=0, likeNumber=0, createdTime=2016-05-07, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a3e6e63697, moduleTitle=Nat Med：T细胞受体疗法(TCR)治疗骨髓瘤疗效良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a3e6e63697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548131, encodeId=bd9b154813114, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Immunity：T细胞受体或可维持调节性T细胞的功能, objectType=article, longId=45395, objectId=b6054539596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6054539596, replyNumber=0, likeNumber=121, createdTime=2015-01-15, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6054539596, moduleTitle=Immunity：T细胞受体或可维持调节性T细胞的功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6054539596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548130, encodeId=c5a915481308c, content=<a href='/topic/show?id=0e021801ee9' target=_blank style='color:#2F92EE;'>#T细胞受体#</a>, objectTitle=Nature:利用人工重构系统研究T细胞受体功能, objectType=article, longId=7597, objectId=abdae59791, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abdae59791, replyNumber=0, likeNumber=83, createdTime=2012-07-05, rootId=0, userName=12498e67m32暂无昵称, userId=df9b14008022, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abdae59791, moduleTitle=Nature:利用人工重构系统研究T细胞受体功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abdae59791)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

T细胞受体

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#p53# #T细胞受体# #MYD88#

2024-07-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#转移性结直肠癌# #T细胞受体# #TCR-T细胞#

2024-07-12发表于上海

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

【Cell】T细胞受体结构图像，揭秘T细胞受体作用机制！

2022-08-24

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Science：通过抓键工程化提高T细胞受体的效力，同时减少脱靶毒性

2022-04-15

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Allergy：T细胞受体测序表明银屑病是是一种以皮肤为重点的过敏原驱动的疾病

2022-03-21

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后

2021-07-06

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Unum Therapeutics宣布研究性新药（IND）申请：抗体偶联T细胞受体（ACTR）细胞疗法和曲妥珠单抗联合治疗HER2阳性晚期癌症

2018-08-16

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Gastroenterology：肠道微生物菌群改变导致肝内γδT细胞受体阳性细胞产生白细胞介素17及胆汁淤积性肝病的发病机制的研究

2018-06-06

zhaojie88 (审核中...)

前往app查看评论内容

#T细胞受体#

J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染

2017-08-04

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

eLife：T细胞受体基因疗法或可有效改善癌症免疫疗法的安全性

2016-11-14

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Science子刊：挑战常规！同一个T细胞受体诱导两种T细胞亚型产生

2016-09-02

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Nat Med：T细胞受体疗法(TCR)治疗骨髓瘤疗效良好

2016-05-07

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Immunity：T细胞受体或可维持调节性T细胞的功能

2015-01-15

12498e67m32暂无昵称 (审核中...)

前往app查看评论内容

#T细胞受体#

Nature:利用人工重构系统研究T细胞受体功能

2012-07-05

科室
- - 订阅+
  - 更多科室
工具
服务